09:01 AM EDT, 05/06/2025 (MT Newswires) -- Harmony Biosciences ( HRMY ) reported Q1 adjusted earnings Tuesday of $1.03 per diluted share, up from $0.88 a year earlier.

Four analysts polled by FactSet expected $0.83.

Revenue for the quarter ended March 31 was $184.7 million, compared with $154.6 million a year earlier.

Analysts surveyed by FactSet expected $182.3 million.

For 2025, the company said it continues to expect revenue of $820 million to $860 million.

Analysts polled by FactSet expect $840.4 million.

The company's shares were up more than 3.5% in recent Tuesday premarket activity.